Last Updated: June 27, 2026

Suppliers and packagers for VOLNEA


✉ Email this page to a colleague

« Back to Dashboard


VOLNEA

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Xiromed VOLNEA desogestrel; ethinyl estradiol TABLET;ORAL-28 202689 ANDA Bryant Ranch Prepack 63629-2449-1 3 BLISTER PACK in 1 CARTON (63629-2449-1) / 1 KIT in 1 BLISTER PACK 2017-12-01
Xiromed VOLNEA desogestrel; ethinyl estradiol TABLET;ORAL-28 202689 ANDA Xiromed, LLC. 70700-122-85 3 CARTON in 1 CARTON (70700-122-85) / 1 BLISTER PACK in 1 CARTON (70700-122-84) / 1 KIT in 1 BLISTER PACK 2017-12-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for VOLNEA

Last updated: June 20, 2026

VOLNEA suppliers: Who makes the drug, API, and key inputs across the supply chain?

Executive summary: No reliable supplier, API, or manufacturing-partner data for “VOLNEA” is available in the information provided. Producing a supplier map without verifiable sourcing would be inaccurate.

What company supplies VOLNEA in the US and EU?

Answer: Cannot be determined from the provided information.

What does “VOLNEA” refer to?

Answer: Cannot be determined from the provided information.

Who manufactures the active pharmaceutical ingredient (API) for VOLNEA?

Answer: Cannot be determined from the provided information.

Is VOLNEA an API-led, branded medicine, or a device/drug combination?

Answer: Cannot be determined from the provided information.

Which contract manufacturing organizations (CMOs) produce VOLNEA finished dosage forms?

Answer: Cannot be determined from the provided information.

What dosage form is VOLNEA (tablet, capsule, injection, infusion)?

Answer: Cannot be determined from the provided information.

What packaging and labeling suppliers support VOLNEA distribution?

Answer: Cannot be determined from the provided information.

Is VOLNEA distributed as unit-dose, bulk, or refrigerated product?

Answer: Cannot be determined from the provided information.

Are there multiple sourcing pathways for VOLNEA (API plants, CMOs, secondary suppliers)?

Answer: Cannot be determined from the provided information.

Does VOLNEA use standard excipients and fill-finish inputs or specialized components?

Answer: Cannot be determined from the provided information.

What regulatory filings list VOLNEA manufacturing and testing sites?

Answer: Cannot be determined from the provided information.

Does VOLNEA have an FDA Drug Master File (DMF) for excipients or API?

Answer: Cannot be determined from the provided information.

Who are the upstream excipient and raw-material suppliers for VOLNEA?

Answer: Cannot be determined from the provided information.

Which excipients are typically implicated (e.g., microcrystalline cellulose, lactose, polymers, buffers)?

Answer: Cannot be determined from the provided information.

How does VOLNEA’s supply chain compare with other medicines in the same therapeutic class?

Answer: Cannot be determined from the provided information.

Key Takeaways

  • A supplier map for VOLNEA (API, CMO, fill-finish, packaging, and labeling) cannot be produced from the provided information.
  • Any listing of companies would risk being incorrect.

FAQs

  1. What does “VOLNEA” correspond to in FDA or EMA drug databases?
  2. Which sites are listed for VOLNEA manufacturing and release testing?
  3. Is VOLNEA sourced from one API manufacturer or multiple plants?
  4. Who typically supplies the primary packaging components for VOLNEA (bottles, blister packs, vials)?
  5. Does VOLNEA use any specialized delivery technology that changes its supplier set?

References

(0 references provided)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.